SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026888
Filing Date
2022-11-10
Accepted
2022-11-10 16:05:53
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20220930_10q.htm   iXBRL 10-Q 955879
2 EXHIBIT 10.1 ex_444526.htm EX-10.1 52245
3 EXHIBIT 31.1 ex_416187.htm EX-31.1 13422
4 EXHIBIT 31.2 ex_416188.htm EX-31.2 13255
5 EXHIBIT 32.1 ex_416189.htm EX-32.1 6701
6 EXHIBIT 32.2 ex_416190.htm EX-32.2 6780
12 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-22-026888.txt   4135061

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220930.xsd EX-101.SCH 42415
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20220930_cal.xml EX-101.CAL 29651
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220930_def.xml EX-101.DEF 233337
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220930_lab.xml EX-101.LAB 230525
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220930_pre.xml EX-101.PRE 256158
48 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220930_10q_htm.xml XML 595797
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 221377042
SIC: 2834 Pharmaceutical Preparations